Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Completed · Phase 3 · Has a placebo group

Conditions studied: Psoriasis

In brief

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.

Key facts

Study ID

NCT03624127

Run by

Bristol-Myers Squibb

People needed

666

Starts

2018-08-07

Expected to finish

2020-09-02

Last updated by the study team

2023-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Plaque psoriasis for at least 6 months
• Moderate to severe disease
• Candidate for phototherapy or systemic therapy

You may not qualify if…

• Other forms of psoriasis
• History of recent infection
• Prior exposure to BMS-986165 or active comparator
• Other protocol defined inclusion/exclusion criteria apply

Where it is running

• Coastal Clinical Research - Mobile — Mobile, Alabama, United States
• Elite Clinical Studies — Phoenix, Arizona, United States
• Arizona Research Center — Phoenix, Arizona, United States
• Synexus - Tucson — Tucson, Arizona, United States
• Hull Dermatology — Rogers, Arkansas, United States
• First OC Dermatology & Belle-Aimee Skincare Clinic Fountain Valley — Fountain Valley, California, United States
• University California at Irvine Dermatology Clinical Research Center — Irvine, California, United States
• Keck School of Medicine — Los Angeles, California, United States
• Dream Team Clinical Research — Pomona, California, United States
• University Dermatology Group — San Diego, California, United States
• Unison Clinical Trials — Sherman Oaks, California, United States
• New England Research Associates — Bridgeport, Connecticut, United States
• Precision Clinical Research — Davie, Florida, United States
• Indago Research and Health Center — Hialeah, Florida, United States
• LCC Medical Research — Miami, Florida, United States
• International Dermatology Research — Miami, Florida, United States
• Well Pharma Medical Research — Miami, Florida, United States
• Miami Dade Medical Research Institute — Miami, Florida, United States
• San Marcus Research Clinic — Miami Lakes, Florida, United States
• Renstar Medical Research — Ocala, Florida, United States
• Ameriderm Research — Ormond Beach, Florida, United States
• Olympian Clinical Research — Tampa, Florida, United States
• Palm Beach Research Center — West Palm Beach, Florida, United States
• Hamilton Dermatology — Alpharetta, Georgia, United States
• Achieve Clinical Research — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.